Volume 120, Issue 6, Pages (May 2001)

Slides:

Advertisements

Similar presentations

Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke Gastroenterology.

Advertisements

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease Richard N. Fedorak, *, Alfred Gangl, ‡, Charles.

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

It's time to bring the best and brightest back to gastroenterology!

Volume 149, Issue 2, Pages e2 (August 2015)

AGA technical review on irritable bowel syndrome

Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis Konstantinos.

Volume 122, Issue 1, Pages (January 2002)

Volume 134, Issue 7, Pages (June 2008)

Volume 123, Issue 1, Pages (July 2002)

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Volume 125, Issue 4, Pages (October 2003)

Volume 119, Issue 4, Pages (October 2000)

Volume 118, Issue 6, Pages (June 2000)

Noncardiac Chest Pain Clinical Gastroenterology and Hepatology

Volume 120, Issue 4, Pages (March 2001)

Volume 138, Issue 2, Pages (February 2010)

Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab William J. Sandborn, Maria T. Abreu, Geert.

Volume 122, Issue 3, Pages (March 2002)

Diagnosis of irritable bowel syndrome

Volume 122, Issue 1, Pages (January 2002)

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? William E. Whitehead, Olafur.

Walter Reinisch, Andrew R. Reinink, Peter D.R. Higgins

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis Maria Theresa Arias, Niels Vande Casteele, Séverine Vermeire,

JOANNE H. VAN WOERT, M.D. Mayo Clinic Proceedings

Long-term outcome after infliximab for refractory ulcerative colitis

Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients Marko Brinar, Séverine.

13C-octanoic acid breath test for gastric emptying rate of solids

Volume 124, Issue 4, Pages (April 2003)

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Spreading and focusing of gluten epitopes in celiac disease

Volume 120, Issue 4, Pages (March 2001)

Volume 120, Issue 3, Pages (February 2001)

European Association for the Study of the Liver Journal of Hepatology

Volume 120, Issue 4, Pages (March 2001)

Epidemiology of opportunistic infections in AIDS patients

Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study William J. Sandborn, William F. Stenson,

Severe Constipation Clinical Gastroenterology and Hepatology

Fecal Coliform Testing to Identify Effective Antibiotic Therapies for Patients With Antibiotic-Resistant Pouchitis Simon D. McLaughlin, Susan K. Clark,

Human Papillomavirus–Related Rectal Squamous Cell Carcinoma in a Patient With Ulcerative Colitis Diagnosed on Narrow-Band Imaging Ivana Dzeletovic, Shabana.

Volume 132, Issue 1, Pages (January 2007)

David H. Bruining, William J. Sandborn

Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis Konstantinos.

Prednisolone and Budesonide for Short- and Long-Term Treatment of Microscopic Colitis: Systematic Review and Meta-analysis Michael J. Stewart, Cynthia.

Lise L. Kjaergard, Sarah L. Frederiksen, Christian Gluud

AGA technical review on nonalcoholic fatty liver disease

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia? Vincenzo Mirone

AGA technical review on celiac sprue

Volume 118, Issue 6, Pages (June 2000)

Volume 124, Issue 4, Pages (April 2003)

Image of the month Gastroenterology

Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity Severine Vermeire, Stefan Schreiber,

Volume 122, Issue 3, Pages (March 2002)

Volume 119, Issue 4, Pages (October 2000)

Chronic Diarrhea Clinical Gastroenterology and Hepatology

Volume 116, Issue 5, Pages (May 1999)

Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis David N. Moskovitz, Gert Van Assche,

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: A prospective, uncontrolled, pilot study Hiroyuki Hanai, Fumitoshi Watanabe,

AGA technical review on osteoporosis in gastrointestinal diseases

Volume 117, Issue 4, Pages (October 1999)

Volume 122, Issue 1, Pages (January 2002)

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Janusz A. Jankowski, Dawn Provenzale, Paul Moayyedi Gastroenterology

Volume 122, Issue 5, Pages (May 2002)

Medical Therapy for Refractory Pediatric Crohn’s Disease

Issue Highlights Clinical Gastroenterology and Hepatology

Distinguishing Patient Satisfaction With Treatment Delivery From Treatment Effect: A Preliminary Investigation of Patient Satisfaction With Symptoms After.

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis Jean-Frédéric Colombel,

An Unusual Skin Manifestation in a Patient With Ulcerative Colitis

Presentation transcript:

Volume 120, Issue 6, Pages 1323-1329 (May 2001) Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis Geert D'Haens, Liesbeth Lemmens, Frederik Nevens, Martin Hiele, Paul Rutgeerts, Lieven Vandeputte, Marc Peeters, Severin Vermeire Gastroenterology Volume 120, Issue 6, Pages 1323-1329 (May 2001) DOI: 10.1053/gast.2001.23983 Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 1 Response to (A) cyclosporine and (B) methylprednisolone treatments in all patients. Scores (Lichtiger score, modified Truelove and Witts) represent those before the start of therapy (day 0, 2) and on day 8 (■). Gastroenterology 2001 120, 1323-1329DOI: (10.1053/gast.2001.23983) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 2 Mean clinical symptom score on the 8 study days in the patients responding to cyclosporine (♦) and methylprednisolone (▴) therapies. Gastroenterology 2001 120, 1323-1329DOI: (10.1053/gast.2001.23983) Copyright © 2001 American Gastroenterological Association Terms and Conditions